Autophagy in Disease and Therapy
Autophagy in Disease and Therapy is a research topic within Epidemiology. Science Explorer counts 32k research works in it since 1956. 39.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of autophagy in various diseases, including neurodegenerative diseases, cancer, and infections. It covers the molecular mechanisms, regulation, and therapeutic implications of autophagy, as well as its interactions with apoptosis, inflammation, and immunity.
- Autophagy
- Disease
- Cellular Self-Digestion
- Mitophagy
- Apoptosis
- Lysosomal Biogenesis
- Parkinson's Disease
- Cancer
- Inflammation
- Immunity
- Research works
- 32k fractional, since 1956
- In the world top 10%
- 12k per year above
- Top-10% rate
- 39.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +42% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autophagy in Disease and Therapy research?
By volume, China and the United States publish the most (4.2k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 4.2k works
- 2 United States 1.1k works
- 3 India 322 works
- 4 Japan 280 works
- 5 South Korea 266 works
- 6 Italy 196 works
- 7 Germany 191 works
- 8 United Kingdom 166 works
- 9 France 139 works
- 10 Iran 134 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autophagy in Disease and Therapy research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Autophagy in Disease and Therapy research, followed by Sun Yat-sen University and Nanjing Medical University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 50 works
- 2 Sun Yat-sen UniversityChina 49 works
- 3 Nanjing Medical UniversityChina 48 works
- 4 Zhejiang UniversityChina 42 works
- 5 Central South UniversityChina 41 works
- 6 China Medical UniversityChina 40 works
- 7 Sichuan UniversityChina 38 works
- 8 Southern Medical UniversityChina 38 works
- 9 Huazhong University of Science and TechnologyChina 38 works
- 10 Shanghai Jiao Tong UniversityChina 36 works
Who are the leading researchers in Autophagy in Disease and Therapy?
The most-cited researchers publishing on Autophagy in Disease and Therapy include Guido Kroemer and Gordon B. Mills.
- 1 Guido Kroemer France 4.2k citations
- 2 Gordon B. Mills United States 3.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autophagy in Disease and Therapy research done?
The largest centres of Autophagy in Disease and Therapy research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Luzhou and Hengyang.
Largest cities, 2022–2025
Where it is the local speciality
- LuzhouCN · 23.7 works12×
- HengyangCN · 26.5 works9.3×
Location quotient: how much more of its research is in Autophagy in Disease and Therapy than the world average.
Where is the best place to study Autophagy in Disease and Therapy?
Among universities, judged by research, China Medical University, Nanjing Medical University and Southern Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | China Medical UniversityChina | 81.3 | 49.7% | 15.7× | 40 | +396.5% |
| 2 | Nanjing Medical UniversityChina | 75.2 | 41.1% | 12.0× | 48 | +153.5% |
| 3 | Southern Medical UniversityChina | 75.2 | 39.9% | 13.2× | 38 | +318.9% |
| 4 | Wenzhou Medical UniversityChina | 72.0 | 39.0% | 11.2× | 31 | +270.9% |
| 5 | China Pharmaceutical UniversityChina | 71.4 | 49.5% | 10.6× | 18 | +183.7% |
| 6 | Northeast Agricultural UniversityChina | 69.7 | 61.9% | 7.1× | 15 | +494.4% |
| 7 | Guangzhou Medical UniversityChina | 69.0 | 39.3% | 10.0× | 21 | +200.7% |
| 8 | Shanghai University of Traditional Chinese MedicineChina | 67.1 | 37.2% | 14.4× | 22 | +659.6% |
| 9 | Chongqing Medical UniversityChina | 66.9 | 30.6% | 12.0× | 32 | +286.8% |
| 10 | Nanjing University of Chinese MedicineChina | 66.9 | 35.0% | 12.8× | 25 | +659.1% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Autophagy in Disease and Therapy research growing?
Output in 2018–2022 was 42% higher than in 2013–2017, peaking in 2022. The fastest-growing topics are Autophagy in Disease and Therapy.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.